Apotheek Jacobs
Timeline
27 events since 2010Board
Filings
Financial
Establishments
201020122014201620182020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBabbreviated format · 29 days before the deadline
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0828618342
Annual accounts 2024 filed PDFabbreviated format · 24 days before the deadline
2024
Annual accounts 2023 filed PDFabbreviated format · 20 days before the deadline
2023
Annual accounts 2022 filed PDFabbreviated format · 31 days late
Change of role: OMNICARE FARMA HOLDING, from manager to director“12. Het onderzoek,de ontwikkeling,de vervaardiging of commercialisering van nieuwe producten,nieuwe vormen van…” (deed in Dutch) · General meeting of 17-03-20234 points ▸
- General meeting, 17-03-2023
- Director resignation, OMNICARE FARMA HOLDING (manager)
- Director appointment, OMNICARE FARMA HOLDING (director (not named in the articles))
- Registered office clause, Lokeren, Markt 75
- The deed holds 5 more points.
2022
Liquidity more than doubled current ratio 9.37 The current ratio rises from 3.69 to 9.37. Short-term debt falls from €103,446 to €33,342.
Annual accounts 2021 filed PDFabbreviated format · 20 days before the deadline
2021
Annual accounts 2020 filed PDFabbreviated format · 95 days late
2020
Highest result from 2011 to 2025 net €68,405 ▲16.4% The net result of €68,405 is the highest of those years.
1 director appointed, 2 resignationsResignations: Tom Jacobs and Debby Van de Vyver · Appointment: BV Omnicare Farma Holding · Permanent representative: Debby Van de Vyver · General meeting of 01-01-20207 points ▸
- General meeting, 01-01-2020
- Director resignation, Tom Jacobs
- Director resignation, Debby Van de Vyver
- Director discharge, Tom Jacobs
- Director discharge, Debby Van de Vyver
- Director appointment, BV Omnicare Farma Holding
- Permanent representative, Debby Van de Vyver
Annual accounts 2019 filed PDFabbreviated format · 28 days late
2019
Annual accounts 2018 filed PDFabbreviated format · 27 days late
2018
Equity above €200,000 equity €216,613 ▲33.8% After 5 profitable years in a row, equity reaches €216,613.
Annual accounts 2017 filed PDFabbreviated format · 27 days late
2017
Equity above €150,000 equity €161,877 ▲34.5% After 4 profitable years in a row, equity reaches €161,877.
Annual accounts 2016 filed PDFabbreviated format · 30 days late
2016
Equity above €100,000 equity €120,330 ▲34.3% After 3 profitable years in a row, equity reaches €120,330.
Annual accounts 2015 filed PDFabbreviated format · 29 days late
2015
Annual accounts 2014 filed PDFabbreviated format · 27 days late
2014
Back to profit net €12,597 The net result is €12,597, after one loss-making year.
Annual accounts 2013 filed PDFabbreviated format · 16 days before the deadline
2013
Weakest financial year net -€4,538 The net result drops to -€4,538, the lowest from 2011 to 2025. It recovers the following year.
Annual accounts 2012 filed PDFabbreviated format · 26 days before the deadline
2012
Annual accounts 2011 filed PDFabbreviated format · 18 days before the deadline
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank